These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 33828027

  • 1. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
    Liu Y, Liu X, Yang S.
    Biol Pharm Bull; 2021 Jun 01; 44(6):861-868. PubMed ID: 33828027
    [Abstract] [Full Text] [Related]

  • 2. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
    Ryu K, Susa M, Choy E, Yang C, Hornicek FJ, Mankin HJ, Duan Z.
    BMC Cancer; 2010 May 10; 10():187. PubMed ID: 20459702
    [Abstract] [Full Text] [Related]

  • 3. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL, Jiang QC, Wang SR.
    Breast Cancer; 2018 Mar 10; 25(2):233-242. PubMed ID: 29181822
    [Abstract] [Full Text] [Related]

  • 4. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
    Shi X, Valizadeh A, Mir SM, Asemi Z, Karimian A, Majidina M, Safa A, Yosefi B.
    Eur J Pharmacol; 2020 Aug 05; 880():173138. PubMed ID: 32416187
    [Abstract] [Full Text] [Related]

  • 5. Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.
    Lin W, Sun J, Sadahira T, Xu N, Wada K, Liu C, Araki M, Xu A, Watanabe M, Nasu Y, Huang P.
    Int J Biol Sci; 2021 Aug 05; 17(12):3255-3267. PubMed ID: 34421363
    [Abstract] [Full Text] [Related]

  • 6. Cinnamaldehyde derivative (CB-PIC) sensitizes chemo-resistant cancer cells to drug-induced apoptosis via suppression of MDR1 and its upstream STAT3 and AKT signalling.
    Yun M, Lee D, Park MN, Kim EO, Sohn EJ, Kwon BM, Kim SH.
    Cell Physiol Biochem; 2015 Aug 05; 35(5):1821-30. PubMed ID: 25833196
    [Abstract] [Full Text] [Related]

  • 7. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I, Gazzano E, Jean SR, Audrito V, Kopecka J, Fanelli M, Salaroglio IC, Costamagna C, Roato I, Mungo E, Hattinger CM, Deaglio S, Kelley SO, Serra M, Riganti C.
    Mol Cancer Ther; 2016 Nov 05; 15(11):2640-2652. PubMed ID: 27466354
    [Abstract] [Full Text] [Related]

  • 8. Autophagy prevents doxorubicin‑induced apoptosis in osteosarcoma.
    Zhao D, Yuan H, Yi F, Meng C, Zhu Q.
    Mol Med Rep; 2014 May 05; 9(5):1975-81. PubMed ID: 24639013
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pioglitazone, an agonist of PPARγ, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression.
    Higuchi T, Sugisawa N, Miyake K, Oshiro H, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Kline Z, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.
    Biomed Pharmacother; 2019 Oct 05; 118():109356. PubMed ID: 31545293
    [Abstract] [Full Text] [Related]

  • 12. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B, Zhu J, Liu S, Wang L, Fan Q, Hao Y, Fan C, Tang TT.
    Oncotarget; 2016 Jul 26; 7(30):48296-48308. PubMed ID: 27340780
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis.
    Zhao H, Guo W, Peng C, Ji T, Lu X.
    Mol Biol Rep; 2010 Jun 26; 37(5):2509-15. PubMed ID: 19701692
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
    Liu Q, Wang K.
    Cell Biol Int; 2019 Nov 26; 43(11):1245-1256. PubMed ID: 30811078
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Influence of MDR1 Expression Regulated by miR-138 through TRPS1 Signaling Pathway on Multidrug Resistance of Osteosarcoma and Formation of Bacterial Infection Biofilm.
    Fang X, Zhu L, Wu Q, Zhong X, Chen Y, Zhu W.
    Cell Mol Biol (Noisy-le-grand); 2023 May 31; 69(5):51-57. PubMed ID: 37571901
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase 6 regulated expression of IL-8 is involved in the doxorubicin (Dox) resistance of osteosarcoma cells via modulating ABCB1 transcription.
    Cheng M, Cai W, Huang W, Chen Y, Wu Z, Luo P, Yan W.
    Eur J Pharmacol; 2018 Dec 05; 840():1-8. PubMed ID: 30273544
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.